$MLCF Maple Leaf Cement Factory Limited (MLCF): Corporate Briefing 2025 Highlights – By AHCML Research
$MLCF
Maple Leaf Cement Factory Limited
Rs. 93.70
-0.70%
- Maple Leaf Cement Factory Limited (MLCF) held its analyst briefing today to discuss the company’s FY25 financial performance, operational updates, and future outlook. The management provided detailed insights into the challenges faced during the year, strategic initiatives undertaken, and growth opportunities moving forward.
- Novacare, a 99.99%-owned subsidiary of MLCF, is developing its flagship hospital in DHA Phase 5, Islamabad. The project represents a total investment of USD100mn, financed through a balanced 50:50 debt-to-equity structure. The facility is designed to commence operations with a 250-bed capacity, with a built-in provision for future expansion to 450 beds, and is projected for completion by the end of 2026. To strengthen its financial and operational foundation, Novacare has attracted interest from a reputed foreign equity partner, which is slated to acquire a 20% stake in the venture. The project's design is being led by HKS Inc., a premier U.S.-based healthcare architecture firm. Furthermore, a strategic clinical affiliation has been established with the Imperial College Healthcare NHS Trust in London. This partnership is intended to ensure the implementation of world-class standards in facility planning, medical services, technology, and staff training. A key operational benefit will be the facilitation of integrated patient care, including teleconsultations, second opinions, and coordinated international treatment pathways between Pakistan and the UK.